Christa Leisa Frassetto

Title: Christa Leisa Frassetto: Innovator in Pharmaceutical Chemistry

Introduction

Christa Leisa Frassetto is a notable inventor based in Norristown, PA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for treating viral infections.

Latest Patents

Frassetto holds a patent for an anhydrous crystalline free base form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole. This crystalline form is particularly useful in treating infections caused by Picornaviridae, such as human rhinovirus (HRV). The patent also details a method for manufacturing this crystalline form, which includes micronizing the compound particles and potentially using a wetting agent. Additionally, it encompasses pharmaceutical compositions that incorporate this free base crystalline form, such as tablets or suspensions, along with methods for therapeutic treatments.

Career Highlights

Frassetto is associated with Aviragen Therapeutics, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating effective treatments for viral infections, showcasing her expertise in pharmaceutical innovation.

Collaborations

Frassetto has collaborated with notable colleagues, including Edward Lee and David McAllister, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Christa Leisa Frassetto's contributions to pharmaceutical chemistry and her innovative patent highlight her role as a leading inventor in her field. Her work continues to impact the treatment of viral infections, demonstrating the importance of innovation in healthcare.